Under pressure from Trump, Pfizer delays drug price increases

Under pressure from Trump, Pfizer delays drug price increases


Pfizer chief executive Ian Read said late Tuesday his company would delay increasing the prices on dozens of drug products after President Donald Trump publicly berated the firm one day earlier. The company, in a statement, said the price increases would effectively be postponed at least until the beginning of 2019 in order "to give the president an opportunity to work on his blueprint to strengthen the healthcare system and provide more access to patients."



from Biotech News